Heather L. Handl

742 total citations
19 papers, 637 citations indexed

About

Heather L. Handl is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Heather L. Handl has authored 19 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Heather L. Handl's work include Chemical Synthesis and Analysis (9 papers), Receptor Mechanisms and Signaling (7 papers) and Cancer therapeutics and mechanisms (4 papers). Heather L. Handl is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Receptor Mechanisms and Signaling (7 papers) and Cancer therapeutics and mechanisms (4 papers). Heather L. Handl collaborates with scholars based in United States, United Kingdom and China. Heather L. Handl's co-authors include Robert J. Gillies, Victor J. Hruby, Josef Vágner, Eugene A. Mash, J.S. Josan, Henry I. Yamamura, Haiyong Han, Liping Xu, David L. Morse and Ronald M. Lynch and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Biochemistry and Life Sciences.

In The Last Decade

Heather L. Handl

19 papers receiving 624 citations

Peers

Countries citing papers authored by Heather L. Handl

Since Specialization

Citations

This map shows the geographic impact of Heather L. Handl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather L. Handl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather L. Handl more than expected).

Fields of papers citing papers by Heather L. Handl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather L. Handl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather L. Handl. The network helps show where Heather L. Handl may publish in the future.

Co-authorship network of co-authors of Heather L. Handl

This figure shows the co-authorship network connecting the top 25 collaborators of Heather L. Handl. A scholar is included among the top collaborators of Heather L. Handl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather L. Handl. Heather L. Handl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US 2021 ·Current Medical Research and Opinion ·Jason C. Allaire, (unknown), (unknown), Heather L. Handl, (unknown), (unknown)	6
2	Cell-Specific Targeting by Heterobivalent Ligands 2011 ·Bioconjugate Chemistry ·J.S. Josan, Heather L. Handl, (unknown), Liping Xu, Ronald M. Lynch, Josef Vágner, Eugene A. Mash, Victor J. Hruby, Robert J. Gillies	45
3	Heterobivalent Ligands Crosslink Multiple Cell‐Surface Receptors: The Human Melanocortin‐4 and δ‐Opioid Receptors 2008 ·Angewandte Chemie International Edition ·Josef Vágner, Liping Xu, Heather L. Handl, J.S. Josan, David L. Morse, Eugene A. Mash, Robert J. Gillies, Victor J. Hruby	62
4	Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors 2008 ·International Journal of Peptide Research and Therapeutics ·J.S. Josan, Josef Vágner, Heather L. Handl, (unknown), Robert J. Gillies, Victor J. Hruby	29
5	Heterobivalent Ligands Crosslink Multiple Cell‐Surface Receptors: The Human Melanocortin‐4 and δ‐Opioid Receptors 2008 ·Angewandte Chemie ·Josef Vágner, Liping Xu, Heather L. Handl, J.S. Josan, David L. Morse, Eugene A. Mash, Robert J. Gillies, Victor J. Hruby	7
6	Convenient and efficient synthesis of a lanthanide³⁺‐coordinated, diethylene triamine pentaacetic acid labeled biopolymer as an assay for the cholecystokinin B receptor 2007 ·Journal of Applied Polymer Science ·Gao Fen, Heather L. Handl, Josef Vágner, Victor J. Hruby, Robert J. Gillies	2
7	Synthesis and Evaluation of Bivalent NDP-α-MSH(7) Peptide Ligands for Binding to the Human Melanocortin Receptor 4 (hMC4R) 2007 ·Bioconjugate Chemistry ·Heather L. Handl, (unknown), J.S. Josan, Josef Vágner, Eugene A. Mash, Robert J. Gillies, Victor J. Hruby	49
8	Rigid Linkers for Bioactive Peptides 2006 ·Bioconjugate Chemistry ·Josef Vágner, Heather L. Handl, Yasunari Monguchi, Umasish Jana, (unknown), Eugene A. Mash, Victor J. Hruby, Robert J. Gillies	25
9	Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole–imidazole polyamides 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Brian M. Lingerfelt, Heather L. Handl, Konstantinos Kiakos, John A. Hartley, Moses Lee	2
10	Development of a lanthanide-based assay for detection of receptor–ligand interactions at the δ-opioid receptor 2005 ·Analytical Biochemistry ·Heather L. Handl, Josef Vágner, Henry I. Yamamura, Victor J. Hruby, Robert J. Gillies	42
11	Lanthanide-based luminescent assays for ligand-receptor interactions 2005 ·Life Sciences ·Heather L. Handl, Robert J. Gillies	81
12	Design, synthesis, and validation of rigid linkers for bioactive peptides 2005 ·Tetrahedron Letters ·Yasunari Monguchi, Josef Vágner, Heather L. Handl, Umasish Jana, (unknown), Victor J. Hruby, Robert J. Gillies, Eugene A. Mash	9
13	Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Michelle Stewart, Erik Madsen, (unknown), Heather L. Handl, Natalie Brooks, Konstantinos Kiakos, John A. Hartley, Moses Lee	8
14	A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties 2004 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), John D. Trzupek, Shane Roller, (unknown), (unknown), (unknown), (unknown), Heather L. Handl, (unknown), K.A. Johnson, (unknown), Stephen J. Hudson, Konstantinos Kiakos, John A. Hartley, Moses Lee	18
15	Hitting multiple targets with multimeric ligands 2004 ·Expert Opinion on Therapeutic Targets ·Heather L. Handl, Josef Vágner, Haiyong Han, Eugene A. Mash, Victor J. Hruby, Robert J. Gillies	93
16	Lanthanide-based time-resolved fluorescence of in cyto ligand–receptor interactions 2004 ·Analytical Biochemistry ·Heather L. Handl, Josef Vágner, Henry I. Yamamura, Victor J. Hruby, Robert J. Gillies	62
17	Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of α-MSH 2003 ·Bioorganic & Medicinal Chemistry Letters ·Josef Vágner, Heather L. Handl, Robert J. Gillies, Victor J. Hruby	58
18	Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Erik Madsen, Heather L. Handl, Stephen J. Hudson, Richard Hubbard, J. Phillip Bowen, Konstantinos Kiakos, John A. Hartley, Moses Lee	7
19	Novel furano analogues of duocarmycin C1 and C2: design, synthesis, and biological evaluation of seco-iso-Cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-Cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues 2002 ·Bioorganic & Medicinal Chemistry ·(unknown), Brian M. Lingerfelt, (unknown), (unknown), (unknown), (unknown), (unknown), Heather L. Handl, (unknown), Stephen J. Hudson, J. Phillip Bowen, Konstantinos Kiakos, John A. Hartley, Moses Lee	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact